Kymera Therapeutics Inc
NASDAQ:KYMR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
US |
|
K
|
Konami Holdings Corp
LSE:KNM
|
JP |
|
Alpha Group Inc
TSE:3322
|
JP |
|
I
|
Isoenergy Ltd
SWB:I01
|
CA |
|
T
|
TPR Co Ltd
TSE:6463
|
JP |
|
Taichung Commercial Bank Co Ltd
TWSE:2812
|
TW |
Cash Flow Statement
Cash Flow Statement
Kymera Therapeutics Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(48)
|
(44)
|
(46)
|
(59)
|
(58)
|
(79)
|
(100)
|
(124)
|
(139)
|
(154)
|
(155)
|
(159)
|
(158)
|
(168)
|
(147)
|
(155)
|
(158)
|
(167)
|
(224)
|
(241)
|
(275)
|
(295)
|
(311)
|
|
| Depreciation & Amortization |
1
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
4
|
4
|
5
|
6
|
7
|
8
|
8
|
8
|
8
|
|
| Stock-Based Compensation |
2
|
4
|
5
|
8
|
13
|
18
|
25
|
30
|
34
|
35
|
35
|
37
|
39
|
41
|
43
|
46
|
49
|
52
|
55
|
57
|
58
|
59
|
60
|
|
| Other Non-Cash Items |
2
|
4
|
7
|
12
|
17
|
24
|
31
|
35
|
39
|
39
|
36
|
36
|
35
|
36
|
38
|
44
|
44
|
45
|
46
|
44
|
47
|
53
|
55
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(2)
|
136
|
125
|
110
|
98
|
(58)
|
(62)
|
(61)
|
(57)
|
(40)
|
(38)
|
(36)
|
(34)
|
(23)
|
3
|
8
|
2
|
(9)
|
(24)
|
(45)
|
(30)
|
6
|
15
|
|
| Cash from Operating Activities |
(47)
N/A
|
97
N/A
|
88
-10%
|
65
-26%
|
58
-11%
|
(111)
N/A
|
(129)
-16%
|
(146)
-14%
|
(155)
-6%
|
(152)
+2%
|
(153)
-1%
|
(157)
-2%
|
(153)
+2%
|
(151)
+2%
|
(103)
+32%
|
(98)
+4%
|
(106)
-8%
|
(125)
-17%
|
(195)
-56%
|
(234)
-20%
|
(251)
-7%
|
(228)
+9%
|
(233)
-2%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(6)
|
(8)
|
(9)
|
(9)
|
(5)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(6)
|
(16)
|
(23)
|
(34)
|
(38)
|
(32)
|
(23)
|
(13)
|
(6)
|
(2)
|
(2)
|
(1)
|
|
| Other Items |
(95)
|
(349)
|
(413)
|
(369)
|
(229)
|
(33)
|
(98)
|
(116)
|
(95)
|
5
|
23
|
26
|
(10)
|
95
|
174
|
(177)
|
(204)
|
(430)
|
(391)
|
(19)
|
21
|
(56)
|
(520)
|
|
| Cash from Investing Activities |
(101)
N/A
|
(357)
-254%
|
(423)
-18%
|
(378)
+10%
|
(233)
+38%
|
(36)
+85%
|
(100)
-179%
|
(118)
-18%
|
(97)
+18%
|
2
N/A
|
21
+833%
|
19
-6%
|
(27)
N/A
|
71
N/A
|
140
+96%
|
(215)
N/A
|
(235)
-9%
|
(454)
-93%
|
(404)
+11%
|
(25)
+94%
|
20
N/A
|
(58)
N/A
|
(521)
-797%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
114
|
297
|
276
|
277
|
186
|
247
|
249
|
249
|
247
|
154
|
154
|
155
|
156
|
6
|
4
|
357
|
357
|
608
|
610
|
257
|
501
|
290
|
992
|
|
| Net Issuance of Debt |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
|
| Other |
0
|
14
|
14
|
13
|
13
|
2
|
2
|
2
|
2
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
114
N/A
|
310
+173%
|
289
-7%
|
290
+0%
|
199
-31%
|
249
+25%
|
250
+1%
|
250
0%
|
249
-1%
|
153
-38%
|
153
0%
|
154
+1%
|
155
+1%
|
4
-97%
|
4
-3%
|
357
+8 410%
|
357
+0%
|
608
+70%
|
609
+0%
|
255
-58%
|
500
+96%
|
288
-42%
|
991
+244%
|
|
| Change in Cash | ||||||||||||||||||||||||
| Net Change in Cash |
(34)
N/A
|
51
N/A
|
(45)
N/A
|
(23)
+49%
|
24
N/A
|
102
+329%
|
21
-79%
|
(15)
N/A
|
(3)
+77%
|
4
N/A
|
20
+484%
|
16
-20%
|
(25)
N/A
|
(75)
-202%
|
41
N/A
|
43
+4%
|
15
-65%
|
30
+95%
|
10
-65%
|
(4)
N/A
|
268
N/A
|
2
-99%
|
237
+10 489%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(53)
N/A
|
90
N/A
|
79
-12%
|
56
-29%
|
54
-4%
|
(113)
N/A
|
(131)
-15%
|
(148)
-14%
|
(157)
-6%
|
(155)
+1%
|
(156)
-1%
|
(163)
-5%
|
(169)
-4%
|
(174)
-3%
|
(137)
+21%
|
(136)
+1%
|
(138)
-1%
|
(148)
-7%
|
(207)
-40%
|
(240)
-16%
|
(253)
-5%
|
(230)
+9%
|
(234)
-2%
|
|